Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Tests video-game exercise for people with dementia in long-term care

Tests a 12 week exergaming exercise program in people with dementia living in care homes.

Plain-language title generated from the registry record
Registry title: Exergaming Revolution in Dementia

Key facts

Where
Wetzikon, SwitzerlandSee the site

Where in Switzerland

  • Sonnweid AGWetzikon, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Eastern Switzerland University of Applied Sciences
Trial code
NCT06631742
Record updated
8 October 2024
Original description
This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.Read full original descriptionShow less

The Effect of an Exergaming Intervention on Physical Activity and Sleep in People With Major Neurocognitive Disorders Living in Long-term Care Facilities: a Pilot Randomized Controlled Trial.

This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.

Inclusion: Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5); Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30.

Exclusion: Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine; MMSE <5; Planned transfer to another facility within the next 3 months; Acute behavioural problems.

ClinicalTrials.gov NCT06631742